Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Biological, Coronaviruses, multiple myeloma, AML, ALL, Leukemia, sickle cell disease, Adult, antibodies, HSCs, SARS-CoV-2/COVID-19, CLL, Diseases, Lymphoma (any), CML, Bleeding and Clotting, Bone Marrow Failure, LGLL, Hodgkin Lymphoma, CMML, Therapies, Combinations, Elderly, Non-Hodgkin Lymphoma, Adverse Events, Genetic Disorders, MDS, Pediatric, DLBCL, Hemoglobinopathies, MPN, B-Cell Lymphoma, Thrombosis, T-Cell Lymphoma, Plasma Cell Disorders, Cell Lineage, Lymphoid Malignancies, Study Population, Thromboembolism, Clinically relevant, Myeloid Malignancies, transplantation, stem cells
Type: Oral
Hematology Disease Topics & Pathways:
Biological, Coronaviruses, multiple myeloma, AML, ALL, Leukemia, sickle cell disease, Adult, antibodies, HSCs, SARS-CoV-2/COVID-19, CLL, Diseases, Lymphoma (any), CML, Bleeding and Clotting, Bone Marrow Failure, LGLL, Hodgkin Lymphoma, CMML, Therapies, Combinations, Elderly, Non-Hodgkin Lymphoma, Adverse Events, Genetic Disorders, MDS, Pediatric, DLBCL, Hemoglobinopathies, MPN, B-Cell Lymphoma, Thrombosis, T-Cell Lymphoma, Plasma Cell Disorders, Cell Lineage, Lymphoid Malignancies, Study Population, Thromboembolism, Clinically relevant, Myeloid Malignancies, transplantation, stem cells
Saturday, December 5, 2020: 9:30 AM-11:00 AM
Moderators:
Brenda M. Sandmaier, MD, University of Washington School of Medicine, Fred Hutchinson Cancer Research Center
and
Saurabh Chhabra, MD, MS, CIBMTR® (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Medical College of Wiscosin
Disclosures:
Sandmaier: Actinium Pharmaceuticals: Consultancy; Bellicum: Research Funding; AbbVie: Other: Spouse is consultant.
9:30 AM
9:45 AM
10:00 AM
10:15 AM
10:30 AM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH